These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21702397)

  • 21. Tripping with Synthetic Cannabinoids ("Spice"): Anecdotal and Experimental Observations in Animals and Man.
    Järbe TUC; Raghav JG
    Curr Top Behav Neurosci; 2017; 32():263-281. PubMed ID: 27753006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Pharmacological properties and dependence liabilities of synthetic cannabinoids].
    Funada M
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Jun; 45(3):167-74. PubMed ID: 20681249
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Spice/K2 drugs--more than innocent substitutes for marijuana.
    Zawilska JB; Wojcieszak J
    Int J Neuropsychopharmacol; 2014 Mar; 17(3):509-25. PubMed ID: 24169044
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Limits of reactive delusion formation].
    Moefes SM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):277-81. PubMed ID: 3885659
    [No Abstract]   [Full Text] [Related]  

  • 25. Designer drugs. Patients may be using synthetic cannabinoids more than you think.
    Lisi DM
    JEMS; 2014 Sep; 39(9):56-9. PubMed ID: 25322519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Differential approaches to the treatment of acute psychosis due to the use of synthetic cannabinoids].
    Kekelidze ZI; Klimenko TV; Kozlov AA; Shakhova SM
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(12):21-26. PubMed ID: 29376979
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic cannabinoid and cathinone use among US soldiers.
    Berry-Cabán CS; Kleinschmidt PE; Rao DS; Jenkins J
    US Army Med Dep J; 2012; ():19-24. PubMed ID: 23007932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
    Gudsoorkar VS; Perez JA
    Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
    Every-Palmer S
    Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of cannabinoid hyperemesis syndrome caused by synthetic cannabinoids.
    Hopkins CY; Gilchrist BL
    J Emerg Med; 2013 Oct; 45(4):544-6. PubMed ID: 23890687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series.
    Barceló B; Pichini S; López-Corominas V; Gomila I; Yates C; Busardò FP; Pellegrini M
    Forensic Sci Int; 2017 Apr; 273():e10-e14. PubMed ID: 28190538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.
    Dresen S; Ferreirós N; Pütz M; Westphal F; Zimmermann R; Auwärter V
    J Mass Spectrom; 2010 Oct; 45(10):1186-94. PubMed ID: 20857386
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spicing Up Pharmacology: A Review of Synthetic Cannabinoids From Structure to Adverse Events.
    Davidson C; Opacka-Juffry J; Arevalo-Martin A; Garcia-Ovejero D; Molina-Holgado E; Molina-Holgado F
    Adv Pharmacol; 2017; 80():135-168. PubMed ID: 28826533
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ["Railway" paranoid disorder and forced insomnia].
    Moefes SM
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1991; 91(5):95-7. PubMed ID: 1654719
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Spice, bath salts, and the U.S. military: the emergence of synthetic cannabinoid receptor agonists and cathinones in the U.S. Armed Forces.
    Loeffler G; Hurst D; Penn A; Yung K
    Mil Med; 2012 Sep; 177(9):1041-8. PubMed ID: 23025133
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthetic cannabinoid-induced psychosis: two adolescent cases.
    Oluwabusi OO; Lobach L; Akhtar U; Youngman B; Ambrosini PJ
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):393-5. PubMed ID: 23083027
    [No Abstract]   [Full Text] [Related]  

  • 37. Adding Spice to the Porridge: The development of a synthetic cannabinoid market in an English prison.
    Ralphs R; Williams L; Askew R; Norton A
    Int J Drug Policy; 2017 Feb; 40():57-69. PubMed ID: 27955961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. K2 and Spice use among a cohort of college students in southeast region of the USA.
    Egan KL; Suerken CK; Reboussin BA; Spangler J; Wagoner KG; Sutfin EL; Debinski B; Wolfson M
    Am J Drug Alcohol Abuse; 2015; 41(4):317-22. PubMed ID: 26030768
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative assessment of potential abuse liability of natural and synthetic cannabis compounds.
    Mendelson JH; Mello NK; Lex B; Pehrson J; Bavli S
    NIDA Res Monogr; 1983 Apr; 43():132-7. PubMed ID: 6308451
    [No Abstract]   [Full Text] [Related]  

  • 40. Top 10 Facts You Need to Know About Synthetic Cannabinoids: Not So Nice Spice.
    Kemp AM; Clark MS; Dobbs T; Galli R; Sherman J; Cox R
    Am J Med; 2016 Mar; 129(3):240-4.e1. PubMed ID: 26522795
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.